ALT to qHBsAg ratio predicts HBsAg seroclearance in HBeAg-negative hepatitis B patients with Peg-IFN-α-based therapy

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-10-17 DOI:10.1016/j.jhep.2024.10.008

Jian Wang, Qun Zhang, Shaoqiu Zhang, Chao Wu, Rui Huang

引用次数: 0

Abstract

Section snippets

Contributors

Jian Wang: Conceptualization; writing – original draft. Qun Zhang: writing – original draft. Shaoqiu Zhang: writing – original draft. Chao Wu: Conceptualization; writing – review and editing. Rui Huang: Conceptualization; writing – original draft; writing – review and editing; supervision.

Financial support

This work was supported by grants of Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (No. 2022-LCYJ-MS-07 and 2021-LCYJ-PY-43).

Declaration of Competing Interest

None.

Acknowledgements

We thank Chuanwu Zhu and Weimao Ding for data support.

查看原文本刊更多论文

ALT 与 qHBsAg 的比值可预测接受 Peg-IFN-α 治疗的 HBeAg 阴性乙型肝炎患者的 HBsAg 血清清除率

章节片段贡献者王健：构思；撰写-原稿。Qun Zhang：撰写-原稿。Shaoqiu Zhang：撰写-原稿。吴超构思；写作--审阅和编辑。黄锐：构思；撰写-原稿；撰写-审阅和编辑；指导。财务支持本工作得到了南京大学医学院附属鼓楼医院临床试验基金的支持（编号：2022-LCYJ-MS-07 和 2021-LCYJ-PY-43）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.